| 臺大學術典藏 |
2022-03-01T08:20:03Z |
Transesophageal echocardiographic monitoring of critical left ventricular outflow tract obstruction following mitral xenograft replacement - A case report
|
Chan K.-C.; Lin Z.-Y.; Chen T.-H.; Huang Y.-C.; MING-JIUH WANG; Tsai S.-K. |
| 臺大學術典藏 |
2022-01-25T05:10:33Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:58Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; CHUN-JEN LIU; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:57Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh M.-L.; Hung C.-H.; Huang J.-F.; CHUN-JEN LIU; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; Chen D.-S. |
| 國立成功大學 |
2022 |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts
|
Tsai, Y.-T.;Li, C.-Y.;Huang, Y.-H.;Chang, T.-S.;Lin, C.-Y.;Chuang, Chuang C.-H.;Wang, C.-Y.;Anuraga, G.;Chang, T.-H.;Shih, T.-C.;Lin, Z.-Y.;Chen, Y.-L.;Chung, I.;Lee, K.-H.;Chang, Chang C.-C.;Sung, Sung S.-Y.;Yang, K.-H.;Tsui, W.-L.;Yap, C.-V.;Wu, M.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:14Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; JIA-HORNG KAO; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:12Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:11:54Z |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu M.-L.; Liu C.-H.; Huang C.-F.; Tseng T.-C.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:49Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang C.-F.; Yu M.-L.; JIA-HORNG KAO; Tseng T.-C.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; Liu C.-H. |
| 臺大學術典藏 |
2021-07-17T00:58:57Z |
New secondary metabolite with cytotoxicity from spawning soft coral Asterospicularia laurae in Taiwan
|
Su J.-H;Liu C.-I;Lu M.-C;Chang C.-I;Hsieh M.-Y;Lin Y.-C;Dai C.-F;Zhang Y.-H;Lin Z.-Y;Lin Y.-S.; Su J.-H; Liu C.-I; Lu M.-C; Chang C.-I; Hsieh M.-Y; Lin Y.-C; Dai C.-F; Zhang Y.-H; Lin Z.-Y; Lin Y.-S.; CHANG-FENG DAI |
| 臺大學術典藏 |
2021-07-03T03:34:42Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:39Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:50Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; CHEN-HUA LIU; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-05-24T07:20:44Z |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu M.-L.; CHEN-HUA LIU; Huang C.-F.; Tseng T.-C.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:42Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang C.-F.; Yu M.-L.; Kao J.-H.; Tseng T.-C.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; CHEN-HUA LIU |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; TUNG-HUNG SU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-27T06:51:42Z |
New secondary metabolite with cytotoxicity from spawning soft coral Asterospicularia laurae in Taiwan
|
Su, J.-H.;Liu, C.-I.;Lu, M.-C.;Chang, C.-I.;Hsieh, M.-Y.;Lin, Y.-C.;Dai, C.-F.;Zhang, Y.-H.;Lin, Z.-Y.;Lin, Y.-S.; Su, J.-H.; Liu, C.-I.; Lu, M.-C.; Chang, C.-I.; Hsieh, M.-Y.; Lin, Y.-C.; Dai, C.-F.; Zhang, Y.-H.; Lin, Z.-Y.; Lin, Y.-S.; CHANG-FENG DAI |
| 臺大學術典藏 |
2021-01-27T03:21:44Z |
New secondary metabolite with cytotoxicity from spawning soft coral Asterospicularia laurae in Taiwan
|
Su, J.-H.;Liu, C.-I.;Lu, M.-C.;Chang, C.-I.;Hsieh, M.-Y.;Lin, Y.-C.;Dai, C.-F.;Zhang, Y.-H.;Lin, Z.-Y.;Lin, Y.-S.; Su, J.-H.; Liu, C.-I.; Lu, M.-C.; Chang, C.-I.; Hsieh, M.-Y.; Lin, Y.-C.; Dai, C.-F.; Zhang, Y.-H.; Lin, Z.-Y.; Lin, Y.-S.; CHANG-FENG DAI |
| 臺大學術典藏 |
2020-12-28T06:26:47Z |
Who survives cardiac arrest in the intensive care units?
|
Chen W.-J.; Chen S.-C.; Ma M.H.-M.; Hsu C.-Y.; MIN-SHAN TSAI; Lin Z.-Y.; Lee C.-H.; Chen Y.-T.; Chang S.-H.; Huang C.-H.; Shih C.-L.; Lee C.-C.; Chang W.-T. |
| 臺大學術典藏 |
2020-12-24T07:08:29Z |
Who survives cardiac arrest in the intensive care units?
|
Chen W.-J.; Chen S.-C.; Ma M.H.-M.; Hsu C.-Y.; Tsai M.-S.; Lin Z.-Y.; Lee C.-H.; Chen Y.-T.; WEI-TIEN CHANG; Chang S.-H.; Huang C.-H.; Shih C.-L.; Lee C.-C. |
| 臺大學術典藏 |
2020-12-21T08:16:42Z |
Who survives cardiac arrest in the intensive care units?
|
WEN-JONE CHEN; Chen S.-C.; Ma M.H.-M.; Hsu C.-Y.; Tsai M.-S.; Lin Z.-Y.; Lee C.-H.; Chen Y.-T.; Chang W.-T.; Lee C.-C.; Shih C.-L.; Huang C.-H.; Chang S.-H. |
| 臺大學術典藏 |
2020-12-21T03:38:28Z |
Who survives cardiac arrest in the intensive care units?
|
Chang S.-H.; Huang C.-H.; Shih C.-L.; Lee C.-C.; Chang W.-T.; Chen Y.-T.; Lee C.-H.; Lin Z.-Y.; Tsai M.-S.; Hsu C.-Y.; MATTHEW HUEI-MING MA; Chen S.-C.; Chen W.-J. |
| 臺大學術典藏 |
2020-12-16T08:52:34Z |
Who survives cardiac arrest in the intensive care units?
|
Chang S.-H.; Huang C.-H.; Shih C.-L.; CHIEN-CHANG LEE; Chang W.-T.; Chen Y.-T.; Lee C.-H.; Lin Z.-Y.; Tsai M.-S.; Hsu C.-Y.; Ma M.H.-M.; Chen S.-C.; Chen W.-J. |
| 臺大學術典藏 |
2020-12-16T07:56:49Z |
Who survives cardiac arrest in the intensive care units?
|
Chang S.-H.;Huang C.-H.;Shih C.-L.;Lee C.-C.;Chang W.-T.;Chen Y.-T.;Lee C.-H.;Lin Z.-Y.;Tsai M.-S.;Hsu C.-Y.;Ma M.H.-M.;Shyr-Chyr Chen;Chen W.-J.; Chang S.-H.; Huang C.-H.; Shih C.-L.; Lee C.-C.; Chang W.-T.; Chen Y.-T.; Lee C.-H.; Lin Z.-Y.; Tsai M.-S.; Hsu C.-Y.; Ma M.H.-M.; SHYR-CHYR CHEN; Chen W.-J. |
| 臺大學術典藏 |
2020-12-16T07:42:37Z |
Who survives cardiac arrest in the intensive care units?
|
Chang S.-H.;Chien-Hua Huang;Shih C.-L.;Lee C.-C.;Chang W.-T.;Chen Y.-T.;Lee C.-H.;Lin Z.-Y.;Tsai M.-S.;Hsu C.-Y.;Ma M.H.-M.;Chen S.-C.;Chen W.-J.; Chang S.-H.; CHIEN-HUA HUANG; Shih C.-L.; Lee C.-C.; Chang W.-T.; Chen Y.-T.; Lee C.-H.; Lin Z.-Y.; Tsai M.-S.; Hsu C.-Y.; Ma M.H.-M.; Chen S.-C.; Chen W.-J. |
